Sandoz Inc Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Sandoz Inc's Family Patents


Family Patents



Sandoz Inc Drug List

Given below is the complete list of Sandoz Inc's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sandoz Inc News

AstraZeneca and Merck introduce a new patent in their efforts to protect Lynparza from generic competition

21 Nov, 2024

The US Supreme Court decides not to review patent clash involving popular Bausch diarrhea medication

18 Nov, 2024

Bristol-Myers Squibb prevails in legal battle with Sandoz regarding apixaban/Eliquis - JUVE Patent

06 Nov, 2024

FDA grants approval to Fresenius Kabi for biosimilar of Stelara called Otulfi, announces Pharmaceutical Technology

01 Oct, 2024

See More